NCT02811510View on ClinicalTrials.gov

Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans: Sub-Study I

PHASE1RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

June 30, 2026

Study Completion Date

December 31, 2026

Conditions
Cannabis
Interventions
DRUG

Placebo

Placebo pill (no active cannabinoids)

DRUG

Dronabinol

10 mg capsule of Dronabinol will be administered orally.

Trial Locations (1)

06516

RECRUITING

Biological Studies Unit at the VA Connecticut Healthcare System, Yale School of Medicine, West Haven

All Listed Sponsors
lead

Yale University

OTHER